Pharma and Biotech
Notice of Results | 22-Aug-2023 | 07:00 | RNS |
First Dose Administered & Pain Specialist Adviser | 27-Jul-2023 | 07:00 | RNS |
Director/PDMR Share Purchases | 17-Jul-2023 | 13:16 | RNS |
Expansion into oncology | 17-Jul-2023 | 07:00 | RNS |
Appointment of Chief Medical Officer | 08-Jun-2023 | 07:00 | RNS |
MHRA & REC 2 Approval for Phase 1 Clinical Trial | 17-May-2023 | 07:00 | RNS |
Directorate Change, Renewal of Licence & Update | 12-Apr-2023 | 07:00 | RNS |
Second Price Monitoring Extn | 14-Mar-2023 | 14:05 | RNS |
Price Monitoring Extension | 14-Mar-2023 | 14:00 | RNS |
Price Monitoring Extension | 13-Mar-2023 | 16:35 | RNS |
Second Price Monitoring Extn | 07-Mar-2023 | 11:05 | RNS |
Price Monitoring Extension | 07-Mar-2023 | 11:00 | RNS |
Second Price Monitoring Extn | 06-Mar-2023 | 11:05 | RNS |
Price Monitoring Extension | 06-Mar-2023 | 11:00 | RNS |
Holding in Company | 25-Jan-2023 | 12:09 | RNS |
Currency | UK Pounds |
Share Price | 0.15p |
Change Today | 0.005p |
% Change | -3.33 % |
52 Week High | 1.30 |
52 Week Low | 0.13 |
Volume | 2,585,047 |
Shares Issued | 1,088.42m |
Market Cap | £1.58m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
11:36 | 4,660 @ 0.13p |
11:00 | 200,000 @ 0.16p |
11:00 | 6,536 @ 0.16p |
11:00 | 96,732 @ 0.16p |
11:00 | 96,732 @ 0.16p |
CEO | Clarissa Ann Sowemimo- Coke |
You are here: research